The Asahi Intecc PTCA Chronic Total Occlusion Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 163 participants.

Also called NCT02379923

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 163 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02379923
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02379923. Allocation not applicable; no masking; primary purpose treatment. Start 2015-06 (registry gives no type); primary completion 2016-01 (actual). Results posted on 2018-07-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Asahi Intecc PTCA Chronic Total Occlusion Study
Acronym
CTO-PCI
Condition
Coronary Artery Chronic Total Occlusion
Intervention (Device)
Crossing of Coronary Artery CTO
Lead sponsor
Asahi Intecc USA Inc (class: industry)
Collaborator
Medpace, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02379923
Content hash
67a81a036ed3623b1a84c15ca83ec18a4e7b0b265b3a1e3b23b85f923242da3e